386967007: Troglitazone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\...

\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Troglitazone (substance)

\Peroxisome proliferator-activated gamma receptor agonist\Thiazolidinedione (substance)\Troglitazone (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Troglitazone (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Troglitazone (substance)

\Organic compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Troglitazone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461145013 Troglitazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481081017 Troglitazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Troglitazone (substance)	Is a	Thiazolidinedione (substance)	true	Inferred relationship	Some
Troglitazone (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Peroxisome proliferator-activated gamma receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing troglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone (substance)	Inferred relationship	Some
Troglitazone 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone (substance)	Inferred relationship	Some
Troglitazone 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone (substance)	Inferred relationship	Some
Troglitazone 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 300 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 400 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 400 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone 300 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Troglitazone (substance)	Inferred relationship	Some	1
Troglitazone-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Troglitazone (substance)	Inferred relationship	Some	1
Product containing only troglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Troglitazone (substance)	Inferred relationship	Some	1
Product containing only troglitazone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Troglitazone (substance)	Inferred relationship	Some	1

This concept is not in any reference sets